Our data showed that GR can be detected in the cytoplasm of breast cancer cells and isoform-specific antibodies are crucial for detecting GR in breast cancer and understanding its clinicopathological associations, which may explain the conflicting literature findings. Here, NR3C1 is linked to breast cancer.